Literature DB >> 29625277

Loss of p21-activated kinase 1 (Pak1) promotes atrial arrhythmic activity.

Jaime DeSantiago1, Dan J Bare1, Disha Varma2, R John Solaro3, Rishi Arora4, Kathrin Banach5.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is initiated through arrhythmic atrial excitation from outside the sinus node or remodeling of atrial tissue that allows reentry of excitation. Angiotensin II (AngII) has been implicated in the initiation and maintenance of AF through changes in Ca2+ handling and production of reactive oxygen species (ROS).
OBJECTIVE: We aimed to determine the role of p21-activated kinase 1 (Pak1), a downstream target in the AngII signaling cascade, in atrial electrophysiology and arrhythmia.
METHODS: Wild-type and Pak1-/- mice were used to determine atrial function in vivo on the organ and cellular level by quantification of electrophysiological and Ca2+ handling properties.
RESULTS: We demonstrate that reduced Pak1 activity increases the inducibility of atrial arrhythmia in vivo and in vitro. On the cellular level, Pak1-/- atrial myocytes (AMs) exhibit increased basal and AngII (1 μM)-induced ROS production, sensitivity to the NADPH oxidase-2 (NOX2) inhibitors gp91ds-tat and apocynin (1 μM), and enhanced membrane translocation of Ras-related C3 substrate 1 (Rac1) that is part of the multimolecular NOX2 complex. Upon stimulation with AngII, Pak1-/- AMs exhibit an exaggerated increase in the intracellular Calcium concentration ([Ca2+]i) and arrhythmic events that were sensitive to sodium-calcium exchanger (NCX) inhibitors (KB-R7943 and SEA0400; 1 μM) and suppressed in AMs from NOX2-deficient (gp91phox-/-) mice. Pak1 stimulation (FTY720; 200 nM) in wild-type AMs and AMs from a canine model of ventricular tachypacing-induced AF prevented AngII-induced arrhythmic Ca2+ overload by attenuating NCX activity in a NOX2-dependent manner.
CONCLUSION: The experimental results support that Pak1 stimulation can attenuate NCX-dependent Ca2+ overload and prevent triggered arrhythmic activity by suppressing NOX2-dependent ROS production.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Excitation-contraction coupling; NADPH oxidase-2; Reactive oxygen species; p21-activated kinase

Mesh:

Substances:

Year:  2018        PMID: 29625277      PMCID: PMC7017889          DOI: 10.1016/j.hrthm.2018.03.041

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  33 in total

1.  Two pathways of activation of the superoxide-generating NADPH oxidase of phagocytes in vitro--distinctive effects of inhibitors.

Authors:  Natalia Sigal; Yara Gorzalczany; Edgar Pick
Journal:  Inflammation       Date:  2003-06       Impact factor: 4.092

2.  An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.

Authors:  Sean W Deacon; Alexander Beeser; Jami A Fukui; Ulrike E E Rennefahrt; Cynthia Myers; Jonathan Chernoff; Jeffrey R Peterson
Journal:  Chem Biol       Date:  2008-04

Review 3.  Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.

Authors:  Jordi Heijman; Niels Voigt; Stanley Nattel; Dobromir Dobrev
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

4.  Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.

Authors:  Boon-Hor Chong; Vincent Pong; Kwok-Fai Lam; Shasha Liu; Ming-Liang Zuo; Yuk-Fai Lau; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal:  Europace       Date:  2011-12-19       Impact factor: 5.214

5.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling.

Authors:  Jen-Ping Chang; Mien-Cheng Chen; Wen-Hao Liu; Cheng-Hsu Yang; Chien-Jen Chen; Yung-Lung Chen; Kuo-Li Pan; Tzu-Hsien Tsai; Hsueh-Wen Chang
Journal:  Cardiovasc Pathol       Date:  2010-01-18       Impact factor: 2.185

Review 7.  Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.

Authors:  Stanley Nattel; Ange Maguy; Sabrina Le Bouter; Yung-Hsin Yeh
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 8.  Lone atrial fibrillation: does it exist?

Authors:  D George Wyse; Isabelle C Van Gelder; Patrick T Ellinor; Alan S Go; Jonathan M Kalman; Sanjiv M Narayan; Stanley Nattel; Ulrich Schotten; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

9.  Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.

Authors:  Domenico M Taglieri; Michelle M Monasky; Ivana Knezevic; Katherine A Sheehan; Ming Lei; Xin Wang; Jonathan Chernoff; Beata M Wolska; Yunbo Ke; R John Solaro
Journal:  J Mol Cell Cardiol       Date:  2011-09-24       Impact factor: 5.000

10.  Automatic detection of atrial fibrillation using the coefficient of variation and density histograms of RR and deltaRR intervals.

Authors:  K Tateno; L Glass
Journal:  Med Biol Eng Comput       Date:  2001-11       Impact factor: 3.079

View more
  6 in total

1.  Inositol 1,4,5-trisphosphate receptor - reactive oxygen signaling domain regulates excitation-contraction coupling in atrial myocytes.

Authors:  Disha Varma; Jonathas F Q Almeida; Jaime DeSantiago; Lothar A Blatter; Kathrin Banach
Journal:  J Mol Cell Cardiol       Date:  2021-10-28       Impact factor: 5.000

Review 2.  p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity.

Authors:  Ping Guo; Yufeng Liu; Jingrong Feng; Shihang Tang; Fanyan Wei; Jian Feng
Journal:  Arch Toxicol       Date:  2022-09-18       Impact factor: 6.168

3.  Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.

Authors:  Mary E Haywood; Andrea Cocciolo; Kadijah F Porter; Evgenia Dobrinskikh; Dobromir Slavov; Sharon L Graw; T Brett Reece; Amrut V Ambardekar; Michael R Bristow; Luisa Mestroni; Matthew R G Taylor
Journal:  J Mol Cell Cardiol       Date:  2020-01-18       Impact factor: 5.000

4.  Presence and function of stress granules in atrial fibrillation.

Authors:  Guo Dong; Fengying Liang; Bo Sun; Chengcheng Wang; Yangyang Liu; Xiangpeng Guan; Bo Yang; Chunhong Xiu; Ning Yang; Fengyu Liu; Tianyi Lu; Wei Han
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

5.  Transthyretin deposition alters cardiomyocyte sarcomeric architecture, calcium transients, and contractile force.

Authors:  Kyle T Dittloff; Emanuele Spanghero; Christopher Solís; Kathrin Banach; Brenda Russell
Journal:  Physiol Rep       Date:  2022-03

6.  Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.

Authors:  Masaoki Ito; Carles Codony-Servat; Jordi Codony-Servat; David Lligé; Imane Chaib; Xiaoyan Sun; Jing Miao; Rongwei Sun; Xueting Cai; Alberto Verlicchi; Morihito Okada; Miguel Angel Molina-Vila; Niki Karachaliou; Peng Cao; Rafael Rosell
Journal:  Cell Commun Signal       Date:  2019-10-28       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.